Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypes

American Journal of Medicine

Volumn 111, Issue 9, 2001, Pages 704-711

  Gabarre, Jean ^a   Raphael, Martine ^b   Lepage, Eric ^c   Martin, Antoine ^b   Oksenhendler, Eric ^d   Xerri, Luc ^e   Tulliez, Micheline ^f   Audouin, Josée ^g   Costello, Régis ^e   Golfier, Jean Baptiste ^d   Schlaifer, Daniel ^h   Hequet, Olivier ⁱ   Azar, Nabih ^a   Katlama, Christine ^a   Gisselbrecht, Christian ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f Hôpital Cochin ^*  (France)

^g HÔTEL DIEU   (France)

^h CHU PURPAN   (France)

ⁱ CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOBLASTOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; BURKITT LYMPHOMA; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0035893641     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)01020-8     Document Type: Article

References (49)

1. Disease progression and survival following specific AIDS-defining conditions: A retrospective cohort study of 2048 HIV-infected persons in London
2. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV cohort study
3. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
4. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
5. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy
6. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy
7. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy
8. AIDS-associated non-Hodgkin's lymphoma in San Francisco
9. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection
10. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients
11. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus. Aquitaine cohort, France, 1986-1997
12. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial
13. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival
14. Evolving characteristics of AIDS-related lymphoma
15. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome
16. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases
17. Burkitt's-like lymphomas in AIDS patients. Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas
18. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
19. AIDS-related lymphoid neoplasia. The Memorial Hospital experience
20. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)
21. The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis
22. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: Identification of a subgroup with favorable clinical outcome
23. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
24. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection
25. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage
26. AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation
27. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor
28. International non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma
29. Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma
30. Toxicity and response criteria of the Eastern Cooperative Oncology Group
31. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
32. Updated Kiel classification for lymphomas
33. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
34. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997
35. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site
36. Nonparametric estimation for incomplete observations
37. HIV-associated lymphoma: Histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features
38. HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors
39. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols
40. Treatment of Burkitt's lymphoma in HIV-positive patients
41. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: A single-institution clinicopathologic study of 75 patients
42. AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens
43. Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma
44. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
45. AIDS-associated non-Hodgkin lymphoma
46. AIDS-associated non-Hodgkin lymphoma
47. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
48. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine, and prednisone